Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:48 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2329–2352 of 2,673 matching trials from the live ClinicalTrials.gov search.

Filters: Sponsor: University of San Francisco Clear all

Conditions: Sleep Apnea
Interventions: Health coaching; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Prostate Cancer
Interventions: lycopene supplement, fish oil supplement, Placebo; Dietary Supplement · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: Male only
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2008
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Glaucoma, Ocular Hypertension, Open Angle Glaucoma
Interventions: Nanodropper; Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pancreatitis Biliary, Pancreatitis Acute Biliary, Pancreatitis, Post-ERCP Pancreatitis, Post-ERCP Acute Pancreatitis, Post-ERCP Adverse Events
Interventions: indomethacin; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 860 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Internal Hernia, Mesocolic Hernia, Petersen´s Hernia, Jejunojejunostomy Hernia, Bowel Obstruction, Ischemic Bowel
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 65 Years
Enrollment: 220 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009
U.S. locations: 1
States / cities: Fresno, California

Conditions: Procedures Requiring Anesthesia
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 6 Years to 11 Years
Enrollment: 162 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 3
States / cities: Davis, California • Oakland, California • San Francisco, California

Conditions: Pentalogy of Cantrell, Mutations in Non-muscle Genes
Interventions: Not listed
Lead sponsor: Children's Healthcare of Atlanta; Other
Eligibility: 2 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2012
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: HIV Infections, Kidney Disease, Liver Disease
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 1 Year and older
Enrollment: 275 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2013
U.S. locations: 21
States / cities: Los Angeles, California • San Francisco, California • Washington D.C., District of Columbia + 12 more

Conditions: Chronic Pain
Interventions: Group Acupuncture, Integrative Group Medical Visits; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 360 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Multiple Myeloma, Multiple Myeloma in Relapse, Multiple Myeloma, Refractory, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
Interventions: Pembrolizumab; Biological
Lead sponsor: Alfred Chung, MD; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Age-related Macular Degeneration, Diabetic Retinopathy, Hypertensive Retinopathy, Retinal Vein Occlusion, Retinal Artery Occlusion
Interventions: Phase variance optical coherence tomography (PV-OCT); Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 13 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Clavicle Fracture
Interventions: Surgery; Procedure
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 10 Years to 18 Years
Enrollment: 250 participants
Timeline: 2013 – 2027
U.S. locations: 8
States / cities: Oakland, California • San Diego, California • Atlanta, Georgia + 5 more

Conditions: Obesity, Abdominal, Cancer Prevention
Interventions: SCOPP-CW, Control; Behavioral
Lead sponsor: San Francisco State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Calcium Metabolism
Interventions: Dietary; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 55 Years and older · Female only
Enrollment: 183 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2013
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Smoking, Nicotine Addiction, Surgery
Interventions: ENDD (NJOY), NRT (NicoDerm CQ), telephone counseling, brief advice, brochure; Behavioral · Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Nodule Solitary Pulmonary, Non-small Cell Lung Cancer
Interventions: Guardant Health ct-DNA LUNAR assay; Diagnostic Test
Lead sponsor: University of California, San Francisco; Other
Eligibility: 40 Years and older
Enrollment: 1,440 participants
Timeline: 2017 – 2030
U.S. locations: 3
States / cities: San Francisco, California

Conditions: High Grade Malignant Neuroendocrine Carcinoma (Diagnosis)
Interventions: Pembrolizumab, Irinotecan, Paclitaxel; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2021
U.S. locations: 3
States / cities: San Francisco, California • Boston, Massachusetts • New York, New York

Conditions: Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation, ATM Gene Mutation, PALB2 Gene Mutation
Interventions: Niraparib, Irinotecan; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Inflammation, HIV Infection, Cardiovascular Disease
Interventions: VB-201, Placebo; Drug
Lead sponsor: Priscilla Hsue, MD; Other
Eligibility: 40 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Tobacco Use Disorder
Interventions: Nicotine polacrilex, Bupropion; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 50 Years and older
Enrollment: 403 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2009
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Epilepsy, Seizure Disorder
Interventions: PatientsLikeMe.com; Behavioral
Lead sponsor: Northern California Institute of Research and Education; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hirschsprung Disease
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 13 Years to 100 Years
Enrollment: 1 participant
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Diabetes, Metabolic Syndrome, Insulin Resistance
Interventions: pegvisomant; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 80 Years
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Fontan Procedure, Hypoplastic Left Heart Syndrome, Tricuspid Atresia, Double Inlet Left Ventricle
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 10 Years and older
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: San Francisco, California

Search by objective public record fields.

Reaching for Equity in Sleep Apnea Treatment (REST) Study

Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate Cancer

Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma

Indomethacin for Biliary ERCP Patients

Internal Hernias After Laparoscopic Gastric Bypass

Cognitive Effects of Anesthesia on Children

Genes Mutation Pentalogy of Cantrell

Kidney and Liver Transplantation in People With HIV

Group-based Integrative Pain Management in Primary Care Safety Net Clinics

Pembrolizumab for the Treatment of Relapsed or Refractory Multiple Myeloma After Anti-BCMA CAR-T Therapies

Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging

Multi-Center Adolescent Clavicle Fracture Trial: Operative vs. Non-Operative Treatment

Central Obesity and Cancer Prevention for Chinese American Women

Effect of Dietary Protein Source on Calcium Metabolism

The END Perioperative Smoking Pilot Study

Biomarkers for Risk Stratification in Lung Cancer

Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine Carcinomas

Combination Therapy in Cancers With Mutations in DNA Repair Genes

Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial

Maintaining Nonsmoking: Older Smokers - 1

Policy on Optimal Epilepsy Management

Induced Pluripotent Stem Cells for Disease Research

Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes

Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques